Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Mind over matter: imagining movements boosts stroke recovery

NCT ID NCT02779218

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether combining motor imagery (thinking about moving without actually moving) with a type of brain stimulation called TMS could help people who had a stroke regain arm function. 24 adults who had a stroke at least one month prior participated. The goal was to see if this combination could improve brain signals to the wrist and finger muscles, potentially leading to better recovery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

24 people

The number who actually took part.

Start date

Jan 2013

Finished

Feb 2018

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 18-85 years * Patients who have experienced a Stroke of more than one month * Deficit out of the upper limb (Fugl Meyer member sup \<50/66) * Presence of ECR muscle MEP * Able to carry the motor imagery according to a test by measuring chronometer * Patient who signed informed consent * Subject affiliated to the social security system Exclusion Criteria: * history of epilepsy or seizure * MEP Lack of ECR * Presence of a cons-indication for use of magnetic stimulation or MRI: * Surgical Clips, metal sutures, staples, stent * Osteosynthesis devices on the head or neck * Pacemaker * Implanted hearing aid * Ocular foreign body, shrapnel, bullets * Metal Worker * Heart Valve, endovascular equipment * Ventricular bypass valve * Pace-maker or neurostimulator * Claustrophobia * incapable adult Patient, safeguard justice, guardianship or trusteeship * Pregnant women and / or breastfeeding (because lack of data in the literature regarding the absence of foetotoxic effect)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Stroke are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU Rangueil

    Toulouse, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.